GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » Sale Of Investment

OSE Immunotherapeutics (XPAR:OSE) Sale Of Investment : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Sale Of Investment?

OSE Immunotherapeutics's sale of investment for the six months ended in Jun. 2024 was €0.00 Mil. It means OSE Immunotherapeutics gained €0.00 Mil from selling investments. OSE Immunotherapeutics's sale of investment for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Dec. 2023 ), OSE Immunotherapeutics gained the same money from selling investments in Jun. 2024 (€0.00 Mil).


OSE Immunotherapeutics Sale Of Investment Historical Data

The historical data trend for OSE Immunotherapeutics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Sale Of Investment Chart

OSE Immunotherapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.90 - - - -

OSE Immunotherapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OSE Immunotherapeutics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OSE Immunotherapeutics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


OSE Immunotherapeutics Business Description

Traded in Other Exchanges
Address
22, Boulevard Benoni Goullin, Nantes, FRA, 44200
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics Headlines

No Headlines